GXP Pharmaceuticals Private Limited

GXP Pharmaceuticals Private Limited - business services in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U85191PN2011PTC156428 Incorporated 15 October 2011 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company business services
Data last updated
Revenue · FY 2023
₹12,000
Latest filing
Net loss · FY 2023
₹1.79 Lakh
Latest filing
EBITDA · FY 2023
-₹1.91 Lakh
Latest filing
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹9.5 Cr
No open charges
Company age
15 yrs
Est. 2011
Employees · EPFO
14
Provident fund records

About GXP Pharmaceuticals Private Limited

Data last updated:

GXP Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the business support services segment of the business services sector. It was incorporated on 15 October 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85191PN2011PTC156428. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sanjiv Puri (Managing Director) and Aryan Puri.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 4th Floor Vedwati Apartment Bhavkar Bhavan Lane Shivaji Nagar, Pune, Maharashtra, India – 411005.

As per the financials filed for FY 2023, the company reported a revenue of ₹12,000. For the same year it recorded a net loss of ₹1.79 Lakh and EBITDA of -₹1.91 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 93% over three years and 81% over five years.

The company has about 14 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹9.5 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of GXP Pharmaceuticals Private Limited
CIN U85191PN2011PTC156428
Registration Number 156428
Incorporation Date 15 October 2011
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    4th Floor Vedwati Apartment Bhavkar Bhavan Lane Shivaji Nagar, Pune, Maharashtra, India – 411005
  • Industry
    Business Services, Business Support Services
Comprehensive company report
GXP Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full GXP Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for GXP Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

CIN History of GXP Pharmaceuticals Private Limited

GXP Pharmaceuticals has one previous CIN (Corporate Identification Number): U85191MH2011PTC223090. The current CIN is U85191PN2011PTC156428, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U85191PN2011PTC156428Current
U85191MH2011PTC223090Previous

Business Activity of GXP Pharmaceuticals Private Limited

The main business activity of GXP Pharmaceuticals is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
NAdministrative and support service activities82Office administrative, office support and other business support activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of GXP Pharmaceuticals Private Limited

GXP Pharmaceuticals Private Limited is audited by A V DABAKE & CO for the financial year 2023.

NameStatusAppointment DateCessation Date
A V DABAKE & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of GXP Pharmaceuticals Private Limited

GXP Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aryan PuriDirector29 Dec 20205 Years 9 MonthsCurrent
Anand Virendra JainDirector01 Mar 20215 Years 7 MonthsCurrent
Sanjiv PuriManaging Director15 Oct 201114 Years 11 MonthsCurrent

Financials of GXP Pharmaceuticals Private Limited FY 2024 filings available

GXP Pharmaceuticals Private Limited reported revenue of ₹12,000 for FY 2023.

Revenue · FY 2023
₹12,000
Net loss · FY 2023
₹1.79 Lakh
EBITDA · FY 2023
-₹1.91 Lakh

Compounded Annual Growth Rate (CAGR) of GXP Pharmaceuticals Private Limited

Revenue CAGR growth
3 years · compounded
▼ 93%
5 years · compounded
▼ 81%

Revenue has declined at a compounded annual rate (CAGR) of 81% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of GXP Pharmaceuticals Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue₹12,000••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹1.91 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹1.79 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of GXP Pharmaceuticals Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin••••••••••••••••••••
Net Profit Margin••••••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of GXP Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of GXP Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of GXP Pharmaceuticals Private Limited

Open charges
None
Satisfied charges
₹9.5 Cr
Breakdown by lending institutions
Gvk Biosciences Private Limited₹9.50 Cr
Latest charge details
DateLenderAmountStatus
05 May 2014Gvk Biosciences Private Limited₹9.5 CrSatisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at GXP Pharmaceuticals Private Limited

GXP Pharmaceuticals Private Limited has a workforce of 14 employees as of Mar 30, 2024.

Employee count
14
Active EPFO establishments
1
Employee growth
-22.22%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of GXP Pharmaceuticals Private Limited

GXP Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for GXP Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by GXP Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of GXP Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of GXP Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on GXP Pharmaceuticals Private Limited

Activity
30 Sep 2024
Gxp Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Gxp Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Directors
01 Mar 2021
Anand Virendra Jain was appointed as a Director on 01 Mar 2021 & has been associated with this company since 5 years 7 months.
Directors
29 Dec 2020
Aryan Puri was appointed as a Director on 29 Dec 2020 & has been associated with this company since 5 years 9 months.
Charges
14 Apr 2016
A charge registered on 05 May 2014 via Charge ID 10524286 with Gvk Biosciences Private Limited was fully satisfied on 14 Apr 2016.
Charges
05 May 2014
A charge with Gvk Biosciences Private Limited amounted to Rs. 950.00 Lakh with Charge ID 10524286 was registered on 05 May 2014.

Frequently Asked Questions about GXP Pharmaceuticals Private Limited

GXP Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in business support services, within the business services industry. It was incorporated on 15 October 2011 (15+ years old) and is registered under CIN U85191PN2011PTC156428.

GXP Pharmaceuticals reported revenue of ₹12,000 for FY 2023.

GXP Pharmaceuticals has 3 current directors:

GXP Pharmaceuticals reported a net loss of ₹1.79 Lakh and EBITDA of -₹1.91 Lakh for FY 2023, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of GXP Pharmaceuticals is -93% over three years and -81% over five years. CAGR is the steady yearly rate that links the first and the last year.

No. GXP Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of GXP Pharmaceuticals is U85191PN2011PTC156428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

GXP Pharmaceuticals was incorporated on 15 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Pune.

The registered office of GXP Pharmaceuticals is at 4th Floor Vedwati Apartment Bhavkar Bhavan Lane Shivaji Nagar, Pune, Maharashtra, India – 411005.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available